PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 344 filers reported holding PHARMACYCLICS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,639,000 | +5.7% | 21,589 | +1.6% | 0.06% | -1.7% |
| Q3 2014 | $2,496,000 | +30.9% | 21,255 | 0.0% | 0.06% | +33.3% |
| Q2 2014 | $1,907,000 | -30.9% | 21,255 | -22.8% | 0.04% | -32.8% |
| Q1 2014 | $2,759,000 | -5.3% | 27,533 | 0.0% | 0.07% | -5.6% |
| Q4 2013 | $2,912,000 | -35.4% | 27,533 | -15.5% | 0.07% | -42.3% |
| Q3 2013 | $4,511,000 | +64.8% | 32,590 | -5.4% | 0.12% | +51.9% |
| Q2 2013 | $2,737,000 | – | 34,438 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |